ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nanomedicine Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-20I12321
Home | Market Reports | Science| Engineering & Technology
Global Nanomedicine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Nanomedicine Market Research Report 2024

Code: QYRE-Auto-20I12321
Report
January 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CombiMatrix
Ablynx NV
Abraxis BioScience
Celgene
Mallinckrodt plc
Arrowhead Research
GE Healthcare
Merck
Pfizer Inc
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences

Nanomedicine Market Size

The global Nanomedicine market was valued at US$ 155.5 million in 2023 and is anticipated to reach US$ 246.8 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Nanomedicine Market

Nanomedicine Market

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.
Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.
In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.
Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
This report aims to provide a comprehensive presentation of the global market for Nanomedicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanomedicine.

Report Scope

The Nanomedicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanomedicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanomedicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nanomedicine Market Report

Report Metric Details
Report Name Nanomedicine Market
Accounted market size in 2023 US$ 155.5 million
Forecasted market size in 2030 US$ 246.8 million
CAGR 6.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Quantum dots
  • Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices
Segment by Application
  • oncology
  • Infectious diseases
  • Cardiology
  • Orthopedics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nanomedicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nanomedicine Market growing?

Ans: The Nanomedicine Market witnessing a CAGR of 6.4% during the forecast period 2024-2030.

What is the Nanomedicine Market size in 2030?

Ans: The Nanomedicine Market size in 2030 will be US$ 246.8 million.

Who are the main players in the Nanomedicine Market report?

Ans: The main players in the Nanomedicine Market are Combimatrix, Ablynx, Abraxis Bioscience, Celgene, Mallinckrodt, Arrowhead Research, GE Healthcare, Merck, Pfizer, Nanosphere, Epeius Biotechnologies, Cytimmune Sciences, Nanospectra Biosciences

What are the Application segmentation covered in the Nanomedicine Market report?

Ans: The Applications covered in the Nanomedicine Market report are oncology, Infectious diseases, Cardiology, Orthopedics, Others

What are the Type segmentation covered in the Nanomedicine Market report?

Ans: The Types covered in the Nanomedicine Market report are Quantum dots, Nanoparticles, Nanoshells, Nanotubes, Nanodevices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Quantum dots
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.3 Market by Application
1.3.1 Global Nanomedicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 oncology
1.3.3 Infectious diseases
1.3.4 Cardiology
1.3.5 Orthopedics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicine Market Perspective (2019-2030)
2.2 Nanomedicine Growth Trends by Region
2.2.1 Global Nanomedicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanomedicine Historic Market Size by Region (2019-2024)
2.2.3 Nanomedicine Forecasted Market Size by Region (2025-2030)
2.3 Nanomedicine Market Dynamics
2.3.1 Nanomedicine Industry Trends
2.3.2 Nanomedicine Market Drivers
2.3.3 Nanomedicine Market Challenges
2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicine Players by Revenue
3.1.1 Global Top Nanomedicine Players by Revenue (2019-2024)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2019-2024)
3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanomedicine Revenue
3.4 Global Nanomedicine Market Concentration Ratio
3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2023
3.5 Nanomedicine Key Players Head office and Area Served
3.6 Key Players Nanomedicine Product Solution and Service
3.7 Date of Enter into Nanomedicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
4.1 Global Nanomedicine Historic Market Size by Type (2019-2024)
4.2 Global Nanomedicine Forecasted Market Size by Type (2025-2030)
5 Nanomedicine Breakdown Data by Application
5.1 Global Nanomedicine Historic Market Size by Application (2019-2024)
5.2 Global Nanomedicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanomedicine Market Size (2019-2030)
6.2 North America Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanomedicine Market Size by Country (2019-2024)
6.4 North America Nanomedicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanomedicine Market Size (2019-2030)
7.2 Europe Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanomedicine Market Size by Country (2019-2024)
7.4 Europe Nanomedicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Market Size (2019-2030)
8.2 Asia-Pacific Nanomedicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanomedicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanomedicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanomedicine Market Size (2019-2030)
9.2 Latin America Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanomedicine Market Size by Country (2019-2024)
9.4 Latin America Nanomedicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Market Size (2019-2030)
10.2 Middle East & Africa Nanomedicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanomedicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanomedicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Combimatrix
11.1.1 Combimatrix Company Detail
11.1.2 Combimatrix Business Overview
11.1.3 Combimatrix Nanomedicine Introduction
11.1.4 Combimatrix Revenue in Nanomedicine Business (2019-2024)
11.1.5 Combimatrix Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Detail
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Nanomedicine Introduction
11.2.4 Ablynx Revenue in Nanomedicine Business (2019-2024)
11.2.5 Ablynx Recent Development
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Detail
11.3.2 Abraxis Bioscience Business Overview
11.3.3 Abraxis Bioscience Nanomedicine Introduction
11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2019-2024)
11.3.5 Abraxis Bioscience Recent Development
11.4 Celgene
11.4.1 Celgene Company Detail
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomedicine Introduction
11.4.4 Celgene Revenue in Nanomedicine Business (2019-2024)
11.4.5 Celgene Recent Development
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Detail
11.5.2 Mallinckrodt Business Overview
11.5.3 Mallinckrodt Nanomedicine Introduction
11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2019-2024)
11.5.5 Mallinckrodt Recent Development
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Detail
11.6.2 Arrowhead Research Business Overview
11.6.3 Arrowhead Research Nanomedicine Introduction
11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2019-2024)
11.6.5 Arrowhead Research Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Nanomedicine Introduction
11.7.4 GE Healthcare Revenue in Nanomedicine Business (2019-2024)
11.7.5 GE Healthcare Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Nanomedicine Introduction
11.8.4 Merck Revenue in Nanomedicine Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nanomedicine Introduction
11.9.4 Pfizer Revenue in Nanomedicine Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Nanosphere
11.10.1 Nanosphere Company Detail
11.10.2 Nanosphere Business Overview
11.10.3 Nanosphere Nanomedicine Introduction
11.10.4 Nanosphere Revenue in Nanomedicine Business (2019-2024)
11.10.5 Nanosphere Recent Development
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Detail
11.11.2 Epeius Biotechnologies Business Overview
11.11.3 Epeius Biotechnologies Nanomedicine Introduction
11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2019-2024)
11.11.5 Epeius Biotechnologies Recent Development
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Detail
11.12.2 Cytimmune Sciences Business Overview
11.12.3 Cytimmune Sciences Nanomedicine Introduction
11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2019-2024)
11.12.5 Cytimmune Sciences Recent Development
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Detail
11.13.2 Nanospectra Biosciences Business Overview
11.13.3 Nanospectra Biosciences Nanomedicine Introduction
11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2019-2024)
11.13.5 Nanospectra Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
CombiMatrix
Ablynx NV
Abraxis BioScience
Celgene
Mallinckrodt plc
Arrowhead Research
GE Healthcare
Merck
Pfizer Inc
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
List of Tables
    Table 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Quantum dots
    Table 3. Key Players of Nanoparticles
    Table 4. Key Players of Nanoshells
    Table 5. Key Players of Nanotubes
    Table 6. Key Players of Nanodevices
    Table 7. Global Nanomedicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Nanomedicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Nanomedicine Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Nanomedicine Market Share by Region (2019-2024)
    Table 11. Global Nanomedicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Nanomedicine Market Share by Region (2025-2030)
    Table 13. Nanomedicine Market Trends
    Table 14. Nanomedicine Market Drivers
    Table 15. Nanomedicine Market Challenges
    Table 16. Nanomedicine Market Restraints
    Table 17. Global Nanomedicine Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Nanomedicine Market Share by Players (2019-2024)
    Table 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2023)
    Table 20. Ranking of Global Top Nanomedicine Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Nanomedicine Product Solution and Service
    Table 24. Date of Enter into Nanomedicine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Nanomedicine Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Nanomedicine Revenue Market Share by Type (2019-2024)
    Table 28. Global Nanomedicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Nanomedicine Revenue Market Share by Type (2025-2030)
    Table 30. Global Nanomedicine Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Nanomedicine Revenue Market Share by Application (2019-2024)
    Table 32. Global Nanomedicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Nanomedicine Revenue Market Share by Application (2025-2030)
    Table 34. North America Nanomedicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Nanomedicine Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Nanomedicine Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Nanomedicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Nanomedicine Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Nanomedicine Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Nanomedicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Nanomedicine Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Nanomedicine Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Nanomedicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Nanomedicine Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Nanomedicine Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Nanomedicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Nanomedicine Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Nanomedicine Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Combimatrix Company Detail
    Table 50. Combimatrix Business Overview
    Table 51. Combimatrix Nanomedicine Product
    Table 52. Combimatrix Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 53. Combimatrix Recent Development
    Table 54. Ablynx Company Detail
    Table 55. Ablynx Business Overview
    Table 56. Ablynx Nanomedicine Product
    Table 57. Ablynx Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 58. Ablynx Recent Development
    Table 59. Abraxis Bioscience Company Detail
    Table 60. Abraxis Bioscience Business Overview
    Table 61. Abraxis Bioscience Nanomedicine Product
    Table 62. Abraxis Bioscience Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 63. Abraxis Bioscience Recent Development
    Table 64. Celgene Company Detail
    Table 65. Celgene Business Overview
    Table 66. Celgene Nanomedicine Product
    Table 67. Celgene Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 68. Celgene Recent Development
    Table 69. Mallinckrodt Company Detail
    Table 70. Mallinckrodt Business Overview
    Table 71. Mallinckrodt Nanomedicine Product
    Table 72. Mallinckrodt Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 73. Mallinckrodt Recent Development
    Table 74. Arrowhead Research Company Detail
    Table 75. Arrowhead Research Business Overview
    Table 76. Arrowhead Research Nanomedicine Product
    Table 77. Arrowhead Research Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 78. Arrowhead Research Recent Development
    Table 79. GE Healthcare Company Detail
    Table 80. GE Healthcare Business Overview
    Table 81. GE Healthcare Nanomedicine Product
    Table 82. GE Healthcare Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 83. GE Healthcare Recent Development
    Table 84. Merck Company Detail
    Table 85. Merck Business Overview
    Table 86. Merck Nanomedicine Product
    Table 87. Merck Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 88. Merck Recent Development
    Table 89. Pfizer Company Detail
    Table 90. Pfizer Business Overview
    Table 91. Pfizer Nanomedicine Product
    Table 92. Pfizer Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 93. Pfizer Recent Development
    Table 94. Nanosphere Company Detail
    Table 95. Nanosphere Business Overview
    Table 96. Nanosphere Nanomedicine Product
    Table 97. Nanosphere Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 98. Nanosphere Recent Development
    Table 99. Epeius Biotechnologies Company Detail
    Table 100. Epeius Biotechnologies Business Overview
    Table 101. Epeius Biotechnologies Nanomedicine Product
    Table 102. Epeius Biotechnologies Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 103. Epeius Biotechnologies Recent Development
    Table 104. Cytimmune Sciences Company Detail
    Table 105. Cytimmune Sciences Business Overview
    Table 106. Cytimmune Sciences Nanomedicine Product
    Table 107. Cytimmune Sciences Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 108. Cytimmune Sciences Recent Development
    Table 109. Nanospectra Biosciences Company Detail
    Table 110. Nanospectra Biosciences Business Overview
    Table 111. Nanospectra Biosciences Nanomedicine Product
    Table 112. Nanospectra Biosciences Revenue in Nanomedicine Business (2019-2024) & (US$ Million)
    Table 113. Nanospectra Biosciences Recent Development
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nanomedicine Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Nanomedicine Market Share by Type: 2023 VS 2030
    Figure 3. Quantum dots Features
    Figure 4. Nanoparticles Features
    Figure 5. Nanoshells Features
    Figure 6. Nanotubes Features
    Figure 7. Nanodevices Features
    Figure 8. Global Nanomedicine Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Nanomedicine Market Share by Application: 2023 VS 2030
    Figure 10. oncology Case Studies
    Figure 11. Infectious diseases Case Studies
    Figure 12. Cardiology Case Studies
    Figure 13. Orthopedics Case Studies
    Figure 14. Others Case Studies
    Figure 15. Nanomedicine Report Years Considered
    Figure 16. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Nanomedicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Nanomedicine Market Share by Region: 2023 VS 2030
    Figure 19. Global Nanomedicine Market Share by Players in 2023
    Figure 20. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2023
    Figure 22. North America Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Nanomedicine Market Share by Country (2019-2030)
    Figure 24. United States Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Nanomedicine Market Share by Country (2019-2030)
    Figure 28. Germany Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Nanomedicine Market Share by Region (2019-2030)
    Figure 36. China Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Japan Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. South Korea Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. India Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Australia Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Nanomedicine Market Share by Country (2019-2030)
    Figure 44. Mexico Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brazil Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Nanomedicine Market Share by Country (2019-2030)
    Figure 48. Turkey Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Nanomedicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Combimatrix Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 51. Ablynx Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 52. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 53. Celgene Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 54. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 55. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 56. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 57. Merck Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 58. Pfizer Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 59. Nanosphere Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 60. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 61. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 62. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2019-2024)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cognitive & Artificial Intelligence Systems Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39O6001
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Smart Mobile Robots Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Othe-4A211
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Child Care Robot - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-5N13901
Mon Apr 08 00:00:00 UTC 2024

Add to Cart

Global Live VR Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-19J9893
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions